An observational study in Frailty, Frailty in Older Adults and Frailty/Sarcopenia, sponsored by Universitätsklinikum Hamburg-Eppendorf. Recruiting at 1 site in Germany. Open to participants aged 70 Years and older. Per ClinicalTrials.gov, last updated 2026-07-22.
Sponsored by Universitätsklinikum Hamburg-Eppendorf · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 33 studies in Frailty with a site in Germany — 7 open to participants now, 7 under way, none of them phase 3. Frailty · Germany.
Among the 33 studies in Frailty with a site in Germany, this one is the 8th largest by planned enrollment of the 20 observational ones that give a count, is one of 3 that started in 2025, is one of 20 observational ones, and was the 30th registered.
1,291 studies on the registry are indexed under Frailty; 454 are open to participants now.
Browse Frailty studies →7 of the 33 studies in Frailty with a site in Germany are open now. Recruiting first, the newest first:
University Hospital, Ghent · Sites in Germany, Austria, Belgium and 5 more countries
Ages 18+
Robert Bosch Medical Center · Sites in Germany
Ages 18+
University of Rostock · Sites in Germany
Ages 65+
Universitätsmedizin Mannheim · Sites in Germany
Ages 18+
University of Ulm · Sites in Germany
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 299 Frailty studies recruiting now, 235 (79%) set no upper age limit and 10 (3%) stop at 75 or younger; 7 take children under 18; 66 take healthy volunteers.
This study: 70 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
33 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 3 started in 2025.
This study's planned enrollment of 584 is above the median of 225 across 495 observational studies indexed under Frailty.
Median enrollment 164 across the 13 interventional studies, 203 across the 20 observational. Of the 19 that completed or were terminated, 1 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 33 have an industry lead sponsor. The 10 most frequent:
Universitätsklinikum Hamburg-Eppendorf is the lead sponsor of 416 studies on the registry; 86 are open to participants now.
Universitätsklinikum Hamburg-Eppendorf has 4 studies filed under Frailty — fewer than ten, so there is no comparison to draw.
3 of the studies in Frailty with a site in Germany that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07464106Robert Bosch Medical CenterEvaluation of the Impact of Interventional Treatments for Symptomatic, Severe Tricuspid Valve Insufficiency on Renal Integrity and Function, as Well as on Physical Function and Activity in Older Adults. | 2026-12 |
| NCT07026773University Hospital, GhentValidity of ICU Clinician's Appraisal of Proportionality in CPR | 2026-12-30 |
| NCT06889545Universitätsklinikum Hamburg-EppendorfComparison of Preoperative Frailty Assessment Tools | 2027-11-01 |
Add all 3 to your calendar (.ics) → With an account.
Among the 33 studies in Frailty with a site in Germany, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Frailty is a significant risk factor for postoperative complications and functional decline. Preoperative assessment of frailty is therefore recommended in all older adults. However, despite the availability of many frailty tools, few have been tested in the preoperative setting and there is little comparison of their predictive value in identifying patients at risk. The aim of this study is to investigate which of the following instruments for determining frailty has the highest predictive power with regard to the occurrence of postoperative complications: Risk Analysis Index, Clinical Frailty Scale, the Groningen Frailty Indicator, the Edmonton Frail Scale and the LUCAS-FI. The aim of this research project is to identify a suitable frailty instrument for preoperative risk stratification of older patients during the premedication visit.
Patients of the Medical University Centre Hamburg, Germany
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients at 70 years and above scheduled for surgery
Other: Assessment of frailty using multiple tools
This is an observational study without any intervention. Frailty is assessed using multiple tools and postoperative outcome is compared.
Complications in the first 30 days after surgery
Measured by Clavien-Dindo classification
Time frame: 30 days
Functional state (activities of daily living)
Measured using WHO Disability Assessment Schedule 2.0
Time frame: one, three and six months after surgery
Postoperative Quality of Recovery
Measured by Quality-of-Recovery-15 questionnaire
Time frame: postoperative day 2
Muscle loss during hospitalisation
measured by bioimpedance prior to admission and before discharge from hospital
Time frame: From date of enrollment, up to 4 weeks after surgery
Postoperative delirium
Measured by 3D-Confusion Assessment Method
Time frame: postoperative day 1 to 5
Length of stay
days spent in hospital after surgery
Time frame: from day of surgery, up to 4 weeks after surgery
Discharge destination
e.g.:home, nursing home, other hospital
Time frame: up to 4 weeks after surgery
Cognitive state
Using 5-Minute Montreal Cognitive Assessment (telephone-MOCA). A maximum of 15 points and a minumum of 0 points can be archieved; a higher score indicates better cognitive performance.
Time frame: 3 and 6 months after surgery
Quality-of-Life (QoL)
Measured by WHO-Quality of Life in older adults (WHOQOL-OLD) questionnaire. The WHOQOL-OLD is evaluated by calculating scores for its six facets and summing them, with higher scores indicating a better perceived quality of life.
Time frame: 3 and 6 months after surgery
Frailty progression measured by LUCAS-FI
Frailty assessment with Longitudinal Urban Cohort Aging Study Functional Index (LUCAS-FI)-questionnaire (telephone interview) The LUCAS-FI is evaluated by integrating both risk factors and protective resources, with the balance between them determining the degree of frailty.
Time frame: 3 and 6 months after surgery
Frailty progression measured by GFI (questionnaire)
frailty assessment with Groningen Frailty Indicator (GFI) questionnaire (telephone interview). The GFI is evaluated by summing its item responses, with higher scores indicating a higher degree of frailty.
Time frame: 3 and 6 months after surgery
Frailty progression measured by EFS
Frailty assessment by Edmonton Frail Scale (EFS), (score filled by physician, patient telephone interview). 1 to 10 points can be archieved, more points indicate a greater level of frailty.
Time frame: 3 and 6 months after surgery
Frailty progression by RAI measurement. The Risk Analysis Index (RAI) is evaluated by summing weighted risk factors and protective variables, with higher scores indicating greater patient vulnerability.
Frailty assessment with Risk Analysis Index (index filled by physician, patient telephone interview)
Time frame: 3 and 6 months after surgery
Plan to share: Undecided — Strict data protection guidelines prevent patient data from being made available to third parties. In specific cases, anonymised data may be provided after individual examination and consultation with the responsible ethics committee.
No publications or documents are linked to this record.
Started Apr 2025 (actual). Primary completion is estimated for Nov 2027, 30 months after the start.
Of 291 non-industry observational studies under Frailty, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 55. This study's planned 30 months is close to that.
Counting every sponsor, half of 294 studies reached it within 29 months; a quarter within 12 and three quarters within 55.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universitätsklinikum Hamburg-Eppendorf →